The largest database of trusted experimental protocols

Qiazol lysis reagent

Manufactured by MP Biomedicals
Sourced in United States

QIAzol Lysis Reagent is a ready-to-use solution used for the isolation of total RNA from a variety of biological samples. It is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed to facilitate the lysis of cells and the subsequent isolation of high-quality RNA.

Automatically generated - may contain errors

2 protocols using qiazol lysis reagent

1

RNA Extraction from Frozen Breast Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from frozen breast tissue using the RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany) with the following modification. Samples were homogenized in 2-ml tubes with Lysing Matrix A (MP Biomedicals, Solon, OH, USA) and 1 ml QIAzol Lysis Reagent using a FastPrep-24 5G instrument (MP Biomedicals) with 3 runs of 30 s at 6 m/s. Subsequently, RNA preparation was performed according to the manufacturer’s protocol, including the optional on-column DNase digestion step. RNA concentrations and quality (A260/280, A260/230) were determined by spectrophotometry (Thermo Scientific NanoDrop 1000, Waltham, MA, USA), and samples were stored at − 80 °C until further analysis.
+ Open protocol
+ Expand
2

Evaluating Skin Barrier Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transepidermal water loss (TEWL) was measured using a VapoMeter (Delfin Technologies, Finland). Two sites per mouse were used for TEWL measurements. TEWL values were determined by triplicate measurements and the mean was defined as the TEWL value of every measurement site. After 3 days with skin washes as described above, TEWL was measured and mice were distributed into groups, so that the average TEWL of all groups was similar. On the fourth day, 2 × 108 CFU (4 × 107/cm2) of bacteria or 2.7 μg Sph protein or 50 μg ceramide d18:1/16:0 (N-palmitoyl-D-erythro-sphingosine, Avanti Polar Lipids, Inc.) were applied onto the compromised skin. TEWL was measured again 24 h later. For qRT-PCR of ceramide synthesis enzymes, skin tissues at the application sites were cut and saved in 1 ml of RNAlater solution (Invitrogen) at 4 °C. 50 mg tissue was cut up into small pieces, mixed with 1 ml of QIAzol Lysis Reagent and homogenized using Lysing matrix A (MP Biomedicals) twice at 1800 oscillations/min for 1 min in a FastPrep 96 homogenizer. RNA was extracted following the Qiazol Handbook (Qiagen). Then, the air dried RNA pellet was purified using an RNeasy Plus kit (Qiagen) according to the manufacturer’s protocol. qRT-PCR was performed with a SuperScript III Platinum SYBR Green One-Step qRT-PCR kit (Invitrogen). See Table S2 for oligonucleotides.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!